Showing all 10 results
Accrufer (ferric maltol)
(0 Reviews)
DISEASE INDICATIONS: Iron deficiency
MANUFACTURER: Shield Therapeutics
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Swissmedic (CH)
Accrufer, with the generic name ferric maltol, is a prescription medication used in the treatment of iron deficiency anemia in adults. It is classified as an iron replacement therapy and is designed to help raise and maintain healthy levels of iron in the body.
Adakveo (crizanlizumab)
$1,844.95Rated 5.00 out of 5
(3 Reviews)
DISEASE INDICATIONS: Sickle Cell Disease
MANUFACTURER: Novartis
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Adakveo, with its active ingredient crizanlizumab, is a prescription medication used in the treatment of a specific medical condition known as sickle cell disease (SCD).
$1,844.95
Andexxa (coagulation factor Xa (recombinant), inactivated-zhzo)
$24,063.64Rated 5.00 out of 5
(1 Review)
DISEASE INDICATIONS: Thromboembolism
MANUFACTURER: Alexion Pharmaceuticals
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Andexxa, with its generic name coagulation factor Xa (recombinant), inactivated-zhzo, is a specialized medication used in the field of hematology and coagulation medicine. It is primarily designed to address life-threatening bleeding events or complications associated with the use of certain anticoagulant medications, specifically direct or indirect factor Xa inhibitors.
$24,063.64
Evrenzo (Roxadustat)
From $196.00Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Anemia
MANUFACTURER: Astellas Pharma Inc. FibroGen
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Evrenzo, known by its generic name Roxadustat, is a pharmaceutical medication that belongs to a class of drugs called HIF-PH (Hypoxia-Inducible Factor Prolyl Hydroxylase) inhibitors. This innovative medication is primarily used to treat certain types of anemia, particularly those associated with chronic kidney disease (CKD) and inflammation.
From $196.00
Feraccru (ferric maltol)
$162.85(0 Reviews)
DISEASE INDICATIONS: Iron deficiency
MANUFACTURER: Shield Therapeutics
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Swissmedic (CH)
Feraccru, known by its generic name Ferric Maltol, is a pharmaceutical medication used to treat iron deficiency anemia in adult patients with inflammatory bowel disease (IBD). It is a novel oral iron replacement therapy designed to help replenish iron levels in individuals who have difficulty absorbing iron through their gastrointestinal system.
$162.85
Givlaari (givosiran)
Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Acute Hepatic Porphyria (AHP)
MANUFACTURER: Alnylam Pharmaceuticals
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Givlaari, known by its generic name Givosiran, is a pharmaceutical medication used to treat a rare genetic disorder called acute hepatic porphyria (AHP). This innovative medication represents a significant advancement in the management of this condition, which is characterized by recurrent, severe attacks of abdominal pain, neurological symptoms, and potential life-threatening complications.
Inrebic (fedratinib)
$5,242.36Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Myelofibrosis
MANUFACTURER: Impact Biomedicines, Inc.
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Inrebic, known by its generic name Fedratinib, is a medication used to treat certain rare bone marrow disorders, specifically myelofibrosis.
$5,242.36
Ondexxya (andexanet alfa)
$16,421.35Rated 4.80 out of 5
(5 Reviews)
DISEASE INDICATIONS: Thromboembolism
MANUFACTURER: Alexion Pharmaceuticals
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Ondexxya, known by its generic name Andexanet Alfa, is a medication used as a reversal agent for certain anticoagulant medications. It is primarily used in emergency situations when rapid reversal of the anticoagulant effects is necessary, particularly in cases of life-threatening bleeding or when invasive procedures are required.
$16,421.35
Oxbryta (voxelotor)
$33,074.12Rated 4.80 out of 5
(5 Reviews)
ISEASE INDICATIONS: Sickle Cell Disease
MANUFACTURER: Global Blood Therapeutics, Inc.
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Oxbryta, known by its generic name Voxelotor, is a pharmaceutical medication used to treat a rare genetic blood disorder called sickle cell disease (SCD).
$33,074.12
Ultomiris (ravulizumab)
Rated 4.80 out of 5
(5 Reviews)
MANUFACTURER: Alexion Pharmaceuticals
USAGE: Intravenous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
Ultomiris, known by its generic name Ravulizumab, is a medication used to treat two rare and life-threatening blood disorders, namely paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).
